ReviewCancer management and research2020

Economic Evaluations of Immune Checkpoint Inhibitors for Patients with Non-Small Cell Lung Cancer: A Systematic Review.

Na Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.